Friday, December 9, 2011
Congratulations to Dr. Nancy Klimas
In his fine article today, Cort Johnson brings us another piece of very good news. Dr. Nancy Klimas has been recruited away from the University of Miami, where she has been on the faculty for 27 years. She has been hired to direct a new Neuroimmune Treatment and Research Center at Nova Southeastern University in South Florida. This is an amazing and wonderful bit of news.
A hire of this sort means that the hiring institution has carefully planned it out, and has committed the funds (new hires, research dollars, space) to make this happen. They see something in Dr. Klimas - and they are willing to pay for it - and she sees something in them. This is a really great deal for Dr. Klimas - and the directorship has the further advantage that she does not have to leave her "roots". Dr. Klimas remains in South Florida.
As Dr. Klimas says, this is a chance of a lifetime. Dr. Klimas gets to set up and run her own ME/CFS Research and Treatment Center. She certainly has the connections and qualifications to do this. Congratulations to Dr. Nancy Klimas.
One wonders how many of her team Dr. Klimas will be able to take with her, and who will join her new center as researchers or clinicians? The details will emerge in time, but for the moment we can reassure ourselves that all former cooperative research - with Dr Gordon Broderick and Dr. Mary Ann Fletcher - will continue and, most likely, expand.
This is the third American University or University Hospital "Center for ME/CFS" to have been announced or formed in the last six months. This is unheard of in the world of ME/CFS. To this can be added the alliance of Dr. Daniel Peterson's Simmaron Research with Bond University in Australia. All of these "elevated" situations come as somewhat of a surprise in the wake of other difficulties occurring in the research world of ME/CFS.
As Cort points out, Dr. Nancy Klimas is known for her research collaborations. It is a great asset of Dr. Klimas' - and it is not a characteristic of every researcher. She is special in this regard.
No one person is going to solve this illness. It is going to take many fine minds working together - at various labs and clinical settings. This fusion of assets is going to need some hard work to hammer into shape, but the time to accelerate is now. The real hope is that these new research and treatment centers can expand their collaboration - and build a cohesive network. Let us hope that they have the sense to do this. What is happening at various universities - Harvard, Columbia, Nova Southwest University, Mt. Sinai Hospital, University of Nevada, Cornell, Duke, Stanford, Bond University - is extraordinary. Somehow they are going to have to be encouraged to work together.